OncoCyte Profit Margin

The latest profit margin for 0KCC.L is -2955.63% as of June 2026. That compares with -1489.71% in the prior-year period — down 98.4% year over year. That is below the sector sector average of 22.52%. Investors often review this figure alongside OncoCyte's historical trend and sector peers before judging valuation or financial health.

Over the past year, 0KCC.L's profit margin moved from -1489.71% to -2955.63% — a 98.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OncoCyte's valuation or profitability profile.

Against its sector companies, 0KCC.L currently prints -2955.63% for profit margin, while the sector average sits near 22.52%. That is roughly 13224.2% below the sector mean. Large gaps often invite a closer look at OncoCyte's growth, margins, and balance sheet.

Profit Margin shows how effectively OncoCyte converts resources into returns. At -2955.63%, 0KCC.L may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1489.71% in the prior-year period — down 98.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 0KCC.L's profit margin (-2955.63%), review year-over-year change from -1489.71%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.